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Cardiovascular disease (CVD) is the leading cause of death among
US women, accounting for 25% of all deaths in this population.
Approximately 65% of these deaths occur in asymptomatic wo-
men. Hypertension, hypercholesterolemia, and diabetes mellitus
(diabetes) are major risk factors for CVD and can be treated ef-
fectively if identified at an early stage.
Methods
Data were available from 3,572 uninsured first-time female parti-
cipants aged 40 to 65 years, referred by their health professional to
the South Carolina Well-Integrated Screening and Evaluation for
Women Across the Nation (SC WISEWOMAN), 2009–2012. All
women completed a structured health-risk and behavior question-
naire. Anthropometric measures were recorded and data on clinic-
al risk-factors were collected. Prevalence-ratios (PRs) were ob-
tained by predictive multivariable log-linear modeling.
Results
The prevalence of risk factors was 34.7% for uncontrolled hyper-
tension, 9.3% for hypercholesterolemia, and 21% for diabetes.
Prevalence of untreated hypertension was 15.6%; hypercholester-
olemia, 8%; and diabetes, 4%. The greatest significant predictor of
hypercholesterolemia was hypertension (PR = 4.37) and vice versa
(PR = 2.39). The greatest significant predictors of diabetes were
obesity (PR = 2.23), family history of diabetes (PR = 2.02), and
hypercholesterolemia (PR = 1.85). Being obese (PR = 1.36), over-
weight (PR = 1.23), aged 60 years or more (PR = 1.26), and black
(PR = 1.14) were significant predictors of having at least one CVD
risk factor. Being black (PR = 1.09) was the only significant pre-
dictor of having comorbid conditions.
Conclusion
Prevalence of uncontrolled CVD risk factors was high among par-
ticipants in the SC WISEWOMAN program. These findings con-
firm that the program is reaching high-risk women who are in
need of interventions to reduce their risk for CVD through life-
style changes.
Introduction
Cardiovascular disease (CVD) is the leading cause of death in the
United States overall and among white and black women, account-
ing for 5 of 20 deaths among women in 2009 (1–3). Approxim-
ately 65% of these deaths occurred in asymptomatic women (4).
Hypertension (5,6), hypercholesterolemia (7), and hyperglycemia
(8) are the 3 main risk factors for CVD. Although such conditions
can be treated effectively (9), they may not be highly controlled in
the US population in general and in older women in particular
(10). Women of lower socioeconomic status have higher rates of
CVD and live in an environment that promotes high-risk behavior
(3). A national survey reported a doubling in awareness of CVD
among  women  in  the  past  decade  (3,11),  and  another  study
showed a  positive correlation between women’s  awareness  of
CVD risk and taking a preventive action toward reducing it (12).
More efforts, however, are needed in education and awareness
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campaigns to promote knowledge of CVD and ways to reduce its
burden in highly susceptible populations (3,13,14).
South Carolina is a rural southern state with inadequate health re-
sources and high reported rates of diabetes (12.1%) and stroke
(3.7%) (15). In 2013, 5 of 46 South Carolina counties reported a
shortage of health care providers (16). Under such conditions, it is
crucial to explore state-wide patterns of distribution and treatment
of CVD to provide appropriate case management and health care
and to prevent further development of CVD risk factors among
South Carolina residents.
Our study objective was to determine the prevalence of uncon-
trolled hypertension, hypercholesterolemia, and diabetes and to
identify the predictors of these risk factors among women particip-
ating in the South Carolina Well-Integrated Screening and Evalu-
ation for Women Across the Nation (SC WISEWOMAN) pro-
gram for the first time from 2009 through 2012.
Methods
Study participants
In 2008 the South Carolina Department of Health and Environ-
mental  Control  received funding from the Centers for Disease
Control  and  Prevention  (CDC)  to  implement  the  SC  WISE-
WOMAN program (17), a program that provides screening for
CVD risk factors (diabetes, obesity, hypercholesterolemia, hyper-
tension) and referral to lifestyle interventions that provide counsel-
ing on healthy diets, physical activity, and smoking cessation. Eli-
gibility criteria for SC WISEWOMAN are based on the frame-
work provided by the state’s breast and cervical cancer screening
program,  the  Best  Chance  Network  (BCN),  which  is  part  of
CDC’s National Breast and Cervical Cancer Early Detection Pro-
gram. From May 2009 through June 2012 both the BCN and SC
WISEWOMAN programs were available to 91,145 South Caro-
lina aged 40 to 65. Women could enroll in both programs simul-
taneously at the health center where they received their health care
if that center provided access to both programs. Women were eli-
gible to participate in SC WISEWOMAN only if they had had
breast and cervical cancer screening through the BCN. Of 91,145
South Carolina women eligible for BCN from May 2009 through
June 2012,  9,913 were participating in that  program; 5,429 of
these women were also participating in SC WISEWOMAN. Of
these, 4,266 were first-time SC WISEWOMAN participants (Fig-
ure 1). Our study group consisted of 3,572 of these first-time parti-
cipants for whom complete cross-sectional data were available in-
dicating that they were aged 40 to 65 years, were uninsured or un-
derinsured, were living at or below 200% of the federal poverty
level, and had received screening for breast and cervical cancer
through  the  BCN.  Participants  were  considered  to  be  under-
insured if  their insurance covered hospitalization only. We re-
cruited women from the general South Carolina population by dif-
ferent strategies, including posters, flyers, brochures, and word-of-
mouth. Our study was reviewed and approved by the institutional
review board of the South Carolina Department of Health and En-
vironmental Control.
Figure  1.  Selection  process  for  participants  in  our  study  of  major
cardiovascular risk factors among women participating in the South Carolina
WISEWOMAN program, 2009–2012. Abbreviations: SC BCN, South Carolina
Best Chance Network; LDL, low-density lipoprotein.
 
Data collection
After participants provided consent to trained health professionals,
they were administered a structured health-risk and behavior ques-
tionnaire as required by CDC. The provider (physician, nurse, or
office assistant) filled out the questionnaire if the participant could
not read or write. Information on sociodemographic and behavior-
al factors, personal medical history, and family medical history
was collected. Clinical anthropometric measures were taken dur-
ing a physical examination and included height and weight and
systolic (SBP) and diastolic (DBP) blood pressure measured by
using standard scales. Laboratory tests included total cholesterol,
high-density lipoprotein (HDL) cholesterol, low-density lipopro-
tein (LDL) cholesterol, triglycerides, and blood glucose or blood
hemoglobin A1c (HbA1c). Fasting status was recorded. LDL cho-
lesterol  and triglyceride levels  were calculated only for  parti-
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cipants who were fasting. Screenings were performed at federally
qualified health centers. All centers contracted with Laboratory
Corporation of America to perform blood-work procedures (total
cholesterol,  HDL cholesterol,  LDL cholesterol,  triglycerides,
blood glucose, and HbA1c). SBP and DBP were measured accord-
ing to the Seventh Report of the Joint National Committee on Pre-
vention,  Detection,  Evaluation,  and Treatment  of  High Blood
Pressure guidelines (18).
Study variables
Age was grouped in 3 categories: 49 years or younger, 50 to 59
years, and 60 years or older. Race was defined as either white or
black. Educational level was categorized as high school graduate
or equivalent, more than high school, and less than high school.
Smoking status was defined by answering yes or no to the ques-
tion, “Do you now smoke cigarettes every day, some days, or not
at all?” Body mass index (BMI) was calculated as weight in kilo-
grams divided by height in meters squared (kg/m2) and defined as
underweight (<18.5 kg/m2),  normal weight (25.0–29.9 kg/m2),
overweight (18.5–24.9 kg/m2), or obese (≥30 kg/m2) (19). Clinic-
ally determined blood pressure was classified into 3 groups: pre-
hypertension (SBP ≥120 mm Hg or DBP ≥80 mm Hg), normal
(SBP <120 mm Hg and DBP <80 mm Hg) (20), and hypertension
(SBP ≥140 mm Hg or DBP ≥90 mm Hg among nondiabetic wo-
men and SBP ≥130 mm Hg or DBP ≥80 mm Hg for women with
diabetes) (21).
Total cholesterol level was defined as desirable (<200 mg/dL) or
undesirable (≥200 mg/dL). HDL cholesterol was defined as desir-
able (>59 mg/dL) or undesirable (≤59 mg/dL). LDL cholesterol
was defined as desirable (<130 mg/dL) or undesirable (≥130 mg/
dL) (22).  Triglycerides concentration was defined as desirable
(<150 mg/dL) or undesirable (≥150 mg/dL) (23). Self-reported
family history of heart attack was defined as yes or no to the ques-
tion “Has a doctor, nurse, or other health professional ever told
you that you had any of the following: heart attack (also called
myocardial infarction), angina, coronary heart disease, or stroke?”
We used the same question for diabetes, “Have you ever been told
by a doctor, nurse, or other health professional that you have dia-
betes?” Family history questions were restricted to first-degree rel-
atives (ie, parent, sibling, or child). Self-reported taking of medic-
ation for hypertension, hypercholesterolemia, or diabetes was also
classified by answering yes or no to the question, “Has your fath-
er, brother, son,  mother, sister, or daughter had a stroke or heart
attack before age 55?” Presence of clinically determined hyper-
cholesterolemia was defined as total cholesterol at or above 240
mg/dL.  Presence of  clinically  determined type 2 diabetes  was
defined as fasting blood glucose above 125 mg/dL or nonfasting
blood glucose above 199 mg/dL or if the patient’s medical record
indicated a diagnosis of diabetes. Untreated hypertension (newly
identified hypertension) was defined as women who answered no
to the question “Are you taking any medicine prescribed by your
doctor,  nurse, or other health professional for your high blood
pressure?” but had clinically determined hypertension. Uncon-
trolled cases of hypertension were defined as women with clinic-
ally  determined high blood pressure  who answered yes  to  the
question “Are you taking any medicine prescribed by your doctor,
nurse, or other health professional for your high blood pressure?”
Treated and controlled hypertension was defined as women with
no clinically determined high blood pressure who answered yes to
the question, “Are you taking any medicine prescribed by your
doctor,  nurse, or other health professional for your high blood
pressure?” Hypertension was defined as absent if a woman had no
clinically determined hypertension and answered no to the ques-
tion “Are you taking any medicine prescribed by your doctor,
nurse, or other health professional for your high blood pressure?”
We asked the same questions, substituting hypercholesterolemia
or diabetes for hypertension, to assess participants’ status with re-
spect to these 2 conditions.
Statistical analysis
All computations and statistical analyses were performed by using
SAS 9.3 (SAS Institute, Inc). Descriptive statistics were used to
estimate prevalence of treatment and control of CVD risk factors
(hypertension, hypercholesterolemia, and diabetes), self-reported
family history of heart attack and diabetes, and clinically determ-
ined risk factors for CVD. The prevalence of each CVD risk factor
was determined by each factor’s treatment and control, which was
calculated as the sum of the proportions of those who were un-
treated, uncontrolled, and treated and controlled. To the best of our
knowledge, only Ahluwalia et al. (24) have reported such classi-
fication of risk factor conditions for WISEWOMAN participants.
The relationship between each of the 3 CVD risk factors, treated
as outcome variables, and proposed predictors was assessed separ-
ately by using a log-linear model with the “log” link and Poisson
distribution,  which allows the calculation of  prevalence ratios
(PRs). The same modeling technique was used to determine signi-
ficant predictors of having at least 1 CVD risk factor, and for hav-
ing more than 1 versus only 1. After the multivariable regression
full model was specified, backward elimination was implemented,
and different models were assessed for goodness-of-fit by the like-
lihood ratio test. The full model included diabetes, hypertension,
hypercholesterolemia, age, race, educational level, smoking status,
family history of heart attack, family history of diabetes, and BMI.
Predictors were considered to be significant if their elimination
resulted in a significant likelihood ratio test (P < .05), irrespective
of their individual significance in the model.
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Results
The mean age of the participants was 54 (standard deviation [SD]
= 5.7), ranging from 40 through 65; approximately 50% were aged
50 to 59. Most (59%) were black. Most participants (49%) had a
high school degree; 30% had more than high school, and 22%, less
than high school. About one-third were current smokers. Family
history of diabetes and heart attack was reported by 53% and 35%
of the participants, respectively. The average BMI was 32.4 (SD =
7.6) and ranged from 18.5 to 72.0, with most women in the obese
category (58%); none was underweight. The mean SBP was 130
mm Hg (SD = 18 mm Hg), ranging from 84 to 225 mm Hg, and
the mean DBP was 80 mm Hg (SD = 10 mm Hg), ranging from 49
to 413 mm Hg; 55% were prehypertensive. The average total, fast-
ing or nonfasting, cholesterol level was 201 mg/dL (SD = 43 mg/
dL ); about half had cholesterol levels higher than normal. The
mean HDL level was 57 mg/dL (SD = 17 mg/dL); about 13% had
undesirable levels. The mean level of LDL cholesterol was 119
mg/dL (SD = 38 mg/dL) and was available for 1,754 women, and
that of triglycerides was 121 mg/dL (SD = 80 mg/dL) and was
available for 1,771 women; most had desirable levels of LDL cho-
lesterol (66%) and triglycerides (77%) (Table 1).
The prevalence of untreated diabetes was 4%, and that of uncon-
trolled diabetes, 21%. The prevalence of untreated hypertension
was about 16% and that of uncontrolled hypertension, 35%. The
prevalence of hypercholesterolemia was 8% for untreated and 9%
for uncontrolled. The prevalence of hypertension was 76%; hyper-
cholesterolemia, 68%; and diabetes, 26%, (Figure 2).
Figure 2. Prevalence of cardiovascular risk factors of first-time attendees (n =
3,572) of the South Carolina-WISEWOMAN, 2009–2012.
 
The significant predictors of type 2 diabetes were being older than
60 (PR = 1.35), being black (PR = 1.33), not having a high school
diploma (PR = 1.26), having a family history of diabetes (PR =
2.02), being overweight (PR = 1.68) or obese (PR = 2.23), having
hypercholesterolemia (PR = 1.85), and having hypertension (PR =
1.86) (Table 2). The significant predictors of hypertension were
being black (PR = 1.12) and having hypercholesterolemia (PR =
2.39). The significant predictors of hypercholesterolemia were
having hypertension (PR = 4.37), type 2 diabetes (PR = 1.13), and
being obese (PR = 1.18) or overweight (PR = 1.12). Being aged 50
to 59 years (PR = 1.19) or over 60 years (PR = 1.26), black (PR =
1.14), overweight (PR = 1.23), or obese (PR = 1.36) were signific-
ant predictors of having at least 1 risk factor. However, the only
significant predictor of having more than 1 CVD risk factor was
being black (PR = 1.09) (Table 3) .
Discussion
The prevalence of untreated and uncontrolled diabetes, hyperten-
sion, and hypercholesterolemia was high in this group of low-in-
come, underinsured women in South Carolina. The prevalence of
at least one of these risk factors was higher among women who
were older, black, and overweight or obese. Women newly dia-
gnosed (untreated) with hypertension, hypercholesterolemia, and
type 2 diabetes were identified. SC WISEWOMAN participants
had high rates of uncontrolled hypertension (35%) and type 2 dia-
betes (21%).
Of the 3,572 participants in SC-WISEWOMAN, 50% were aged
50 to 59 years, 59% were black, 31% were current smokers, and
78% had a high-school degree or higher. At initial screening, rates
of high blood cholesterol (48%), hypertension (21%), and dia-
betes (25%) were much higher than those reported in the general
South Carolina population (high blood cholesterol, 41%; hyperten-
sion, 34%; and diabetes, 11% (25).
A recent study of the same program implemented in West Virgin-
ia reported that among 733 participants, 84% were overweight,
44% were prehypertensive, and 45% had high blood cholesterol
levels (24). Another study, which described the WISEWOMAN
program of Nebraska, reported that of 10,739 women screened,
75% were overweight, 56% were prehypertensive, and 20% had
high blood cholesterol levels (26). Our findings are in line with
findings from West Virginia but depart in some instances from
those reported in Nebraska, which could be because geographic-
ally proximal states could share similar culture and dietary habits.
Given the high prevalence of these 3 CVD risk factors, general-
ized linear modeling gave more robust standard errors and a more
meaningful measure of association, the prevalence ratio (27). The
PREVENTING CHRONIC DISEASE                                             VOLUME 11, E153
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY                                             SEPTEMBER 2014
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
                                    the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
4       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2014/14_0044.htm
greatest predictors of type 2 diabetes were obesity (PR = 2.23), hy-
percholesterolemia (PR = 1.85), and hypertension (PR = 1.86). Al-
though educational level was not significant in the final model, its
presence contributed to the prediction of the outcome and reduced
the variance of all other predictors. Hypercholesterolemia was the
major predictor of hypertension (PR = 2.39) and vice versa (PR =
4.37). Unsurprisingly, obesity (PR = 1.36) was the greatest pre-
dictor of having at least 1 CVD risk factor; however, when com-
paring comorbid conditions to a single condition only race re-
mained significant (PR = 1.09).
Our study had some limitations. First, our sample was not random,
which limited the generalizability of our results to the underlying
population; however, this screening program was tailored to tar-
get women at higher risk of developing CVD. Second, not all par-
ticipants were fasting, so measures that require fasting (LDL cho-
lesterol  and triglycerides) were available for only 1,794 parti-
cipants. However, many were recruited on the spot at different
health centers at different times of the day, and fasting could not
be ensured. Third, no information was collected on physical activ-
ity and dietary habits, so we could not assess how those 2 factors
could influence the different  CVD risk factors discussed here.
Fourth, in the absence of a measure of central obesity we could not
evaluate metabolic syndrome (28).
This study also had some strengths. First, the SC WISEWOMAN
program reached 3,572 women at increased risk of developing
CVD and provided subsequent care. Second, it identified new (un-
treated) cases of hypertension, hypercholesterolemia, and diabetes.
Third, we used predictive statistical modeling for which confound-
ing is not a risk, and we reported the prevalence ratio, which ap-
proximates risk better than the odds ratio (27). Fourth, this is the
first study to examine participants of the SC WISEWOMAN pro-
gram. Further research should evaluate the racial disparity in dis-
tribution and prediction of  CVD risk factors  among the parti-
cipants of SC WISEWOMAN program and the effectiveness of
the provided lifestyle interventions over time.
This study emphasizes the need for preventive measures targeted
at hypertension, hypercholesterolemia, and diabetes and strategies
to promote a healthy lifestyle, given the high levels of untreated
and uncontrolled CVD risk factors among women aged 40 years
or older in South Carolina. Our results stress the importance of
checking for comorbidities, especially among higher-risk popula-
tions, and confirm that the program is reaching high-risk women
who are in need of interventions tailored to reduce their risk for
CVD through lifestyle changes. The SC WISEWOMAN screen-
ing program is reaching out to those who are at high risk of devel-
oping CVD and should be expanded to reach a larger geographic
area.
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Tables
Table 1. Distribution of Cardiovascular Risk Factors by Sociodemographic Characteristics Among First-Time Attendees (N = 3,572),




50–59 1, 772 (49.6)





Less than high school 773 (21.6)
High school graduate or equivalent 1,734 (48.6)




Self-reported family history of heart attack
No 2,305 (64.5)
Yes 1,267 (35.5)
Self-reported family history of diabetes
No 1,690 (47.3)
Yes 1,882 (52.7)
Body mass index, kg/m2
Normal weight (25.0–29.9 kg/m2) 540 (15.1)
Overweight (18.5–24.9 kg/m2) 955 (26.7)
Obese (≥30.0 kg/m2) 2,077 (58.2)





a Normal systolic blood pressure (SBP) <120 and normal diasystolic blood pressure (DBP) <80; prehypertension, SBP ≥120 or DBP ≥80; hypertension, SBP ≥140
mm Hg, DBP ≥90 mm Hg for nondiabetic women; SBP ≥130 mm Hg or DBP ≥80 mm Hg for women with diabetes.
b Collected only for participants who were fasting (n = 1,794).
c Low-density lipoprotein cholesterol measurement was missing for 40 fasting participants.
d Triglyceride measurement was missing for 23 fasting participants.
(continued on next page)
PREVENTING CHRONIC DISEASE                                             VOLUME 11, E153
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY                                             SEPTEMBER 2014
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
                                    the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2014/14_0044.htm • Centers for Disease Control and Prevention       7
(continued)
Table 1. Distribution of Cardiovascular Risk Factors by Sociodemographic Characteristics Among First-Time Attendees (N = 3,572),
South Carolina WISEWOMAN Program, 2009–2012
Characteristic n (%)
Desirable (<200) 1,866 (52.2)
Undesirable (≥200) 1,706 (47.8)
High-density lipoprotein cholesterol, mg/dL
Desirable (>59) 2,233 (87.5)
Undesirable (≤59) 447 (12.5)
Low-density lipoprotein cholesterolb, c, mg/dL
Desirable (<130) 1,161 (66.1)
Undesirable (≥130) 594 (33.9)
Triglyceridesb, d, mg/dL
Desirable (<150) 1, 367 (77.2)
Undesirable (≥150) 404 (22.8)
Type 2 diabetes
No 2, 695 (75.5)
Yes 877 (24.5)
a Normal systolic blood pressure (SBP) <120 and normal diasystolic blood pressure (DBP) <80; prehypertension, SBP ≥120 or DBP ≥80; hypertension, SBP ≥140
mm Hg, DBP ≥90 mm Hg for nondiabetic women; SBP ≥130 mm Hg or DBP ≥80 mm Hg for women with diabetes.
b Collected only for participants who were fasting (n = 1,794).
c Low-density lipoprotein cholesterol measurement was missing for 40 fasting participants.
d Triglyceride measurement was missing for 23 fasting participants.
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Table 2. Adjusted Predictors of 3 Baseline Cardiovascular Risk Factors Among First-Time Attendees (N = 3,572), South Carolina
WISEWOMAN Program, 2009–2012a
Characteristic Type 2 Diabetesb Hypertensionc Hypercholesterolemiad
Age, y
≤49 1 [Reference] —e 1 [Reference]
50–59 1.07 (0.90–1.79) —e 1.18 (1.07–1.31)
≥ 60 1.35 (1.12–1.62) —e 1.21 (1.08–1.37)
Race
Black 1.33 (1.15–1.54) 1.12 (1.04–1.22) —e
White 1 [Reference] 1 [Reference] —e
Education
High school graduate or equivalent 0.99 (0.84–1.16) —e —e
More than high school 1 [Reference] —e —e
Less than high school 1.26 (1.06–1.51) —e —e
Self-reported family history of diabetes
Yes 2.02 (1.75–2.33) —e —e
No 1 [Reference] —e —e
BMI (kg/m2)
Normal weight (25–29.9 kg/m2) 1 [Reference] —e 1 [Reference]
Overweight (18.5–24.9 kg/m2) 1.68 (1.23–2.29) —e 1.12 (0.97–1.30)
Obese (≥ 30 Kg/m2) 2.23 (1.67–2.99) —e 1.18 (1.03–1.35)
Hypercholesterolemia
Yes 1.85 (1.47–2.32) 2.39 (2.16–2.65) —e
No 1 [Reference] 1 [Reference] —e
Hypertension
Yes 1.86 (1.40–2.46) —e 4.37 (3.69–5.17)
No 1 [Reference] —e 1 [Reference]
Type 2 Diabetes
Yes —e —e 1.13 (1.04–1.24)
No —e —e 1 [Reference]
Abbreviations: PR, prevalence ratio; CI, confidence interval; BMI, body mass index.
a All values are PR (95% CI). Adjusted for all the other variables in the model.
b Final prediction model was adjusted for age, race, education, self-reported family history of diabetes, BMI, hypercholesterolemia, and hypertension.
c Final prediction model was adjusted for race and hypercholesterolemia
d Final prediction model was adjusted for age, hypertension, and diabetes.
e Does not apply.
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Table 3. Predictors of 3 Baseline Cardiovascular Risk Factors Among First-Time Attendees (N = 3,572), South Carolina WISE-
WOMAN Program, 2009–2012a
Characteristic
At Least 1 Cardiovascular Risk Factorb (n =
3,572)
>1 Versus 1 Cardiovascular Risk Factorc (n
= 2,920)
Age, y
≤49 1 [Reference] —d
50–59 1.19 (1.09–1.30) —d
≥60 1.26 (1.14–1.40) —d
Race
Black 1.14 (1.05–1.22) 1.09 (1.03–1.15)
White 1 [Reference] 1 [Reference]
Body mass index, kg/m2
Normal weight (18.5–24.9) 1 [Reference] —d
Overweight (25.0–29.9) 1.23 (1.08–1.40) —d
Obese (≥30.0) 1.36 (1.20–1.52) —d
Abbreviations: PR, prevalence ratio; CI, confidence interval.
a All values are PR (95% CI). Adjusted for all other significant variables in the model.
b Final prediction model was adjusted for age, race, and body mass index.
c Final prediction model was adjusted for race.
d Does not apply.
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